beta
/Stevanato Group to Participate in Three Upcoming Investor Conferences - May 4, 2026
NEWS

Stevanato Group to Participate in Three Upcoming Investor Conferences - May 4, 2026

BioSpace
2026/05/05
PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences: Tuesday, May 12, at 8:00 a.m. (PT) - Bank of America Global Healthcare Conference in Las Vegas, NV Tuesday, June 2, at 2:40 - 3:10 p.m. (CT) – William Blair Growth Stock Conference in Chicago, IL Thursday, June 4, at 9:55 - 10:25 a.m. (EDT) – Jefferies Healthcare Conference in New York, NY A live webcast for each event will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event. About Stevanato Group Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients. For more information, please visit: www.stevanatogroup.com . Contacts Media Stevanato Group media@stevanatogroup.com Investor Relations Lisa Miles lisa.miles@stevanatogroup.com Giacomo Guiducci giacomo.guiducci@stevanatogroup.com